155
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Bilateral Occlusive Vasculitis Associated with Retinitis Pigmentosa - A Case Report

, DNB, , MS DNB, , DNB & , FRCS DNBORCID Icon
Pages 215-219 | Received 13 May 2021, Accepted 28 Sep 2021, Published online: 19 Nov 2021
 

ABSTRACT

Purpose

To report a case of bilateral occlusive vasculitis associated with retinitis pigmentosa (RP).

Method

Case report.

Case report

A 34-year male presented with blurred vision in left eye (OS) for two weeks and right eye (OD) for one day. He had night blindness for five years. His best corrected visual acuity (BCVA) was OD 20/63 and OS 20/200. Ophthalmoscopy revealed bilateral RP with OD inflammatory central retinal vein occlusion (CRVO) and OS occlusive vasculitis with bilateral macular edema. Presumed intraocular tuberculosis (IOTB) was suspected based on clinical features, positive Mantoux and high-resolution computed tomography chest findings. Oral steroids and antitubercular therapy (ATT) were started. OD received six intravitreal ranibizumab injections. At his 7-month follow-up, BCVA improved, OD 20/40 and OS 20/80.

Conclusion

RP rarely can be associated with presumed IOTB. Oral steroids with ATT are helpful; however, in inflammatory CRVO, intravitreal ranibizumab can give good results.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Patient consent

Written consent to publish this case has not been obtained as this report does not contain any personal identifying information.

Summary

We report a case of 34-year male with bilateral retinitis pigmentosa and presumed tuberculous vasculitis with inflammatory central retinal vein occlusion (CRVO) in one eye. Oral steroids and ATT gave good results. However, intravitreal ranibizumab was a useful adjunct to systemic therapy in managing macular edema due to inflammatory CRVO in RP eyes.

Additional information

Funding

The author(s) reported that there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.